The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Kactus Biosystems
-
11-50 Employees
2018
Key takeaway
KACTUS is a biotech company that specializes in high-purity recombinant proteins and enzymes, including TelN Protelomerase (TLN-BE001), which may be relevant for applications in telomerase research. Their proprietary SAMSâ„¢ platform and commitment to quality support advancements in fields like antibody drug discovery and mRNA therapeutics.
Highlighted product
Product
TelN Protelomerase (TLN-BE001) – KACTUS
Repeat Diagnostics Inc (RepeatDx)
North Vancouver, Canada
A
1-10 Employees
2005
Key takeaway
RepeatDx is a leading clinical diagnostic laboratory that specializes in telomere length testing and is accredited to provide Telomere Length Analysis across all 50 US states and territories. Their research and testing can offer valuable clinical insights, particularly for conditions like myelodysplastic syndromes and acute myeloid leukemia.
Highlighted product
Core business
Telomeres | Telomere Testing | Research on Telomere Aging Process
RepeatDx researches telomeres to combat syndromes such as dyskeratosis congenita through analysis of the telomere aging process.
TelCyte Infrastructure
Dartmouth, Canada
A
11-50 Employees
2017
Key takeaway
TelCyte is a comprehensive telecom and infrastructure solutions provider, emphasizing the importance of structured processes for business success.
Highlighted product
Core business
HOME | Telcyte
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Genebio
-
- Employees
-
Key takeaway
GeneBio Systems offers a partial Recombinant Human Telomerase protein component 1 (TEP1), highlighting their commitment to providing high-performance products for the scientific community, particularly in Molecular and Cellular Biology research.
Highlighted product
Product
Recombinant Human Telomerase protein component 1(TEP1),partial – GeneBio Systems
Recombinant Human Telomerase protein component 1(TEP1),partial
TeloPro Biosciences GmbH
Munich, Germany
A
1-10 Employees
2019
Key takeaway
TeloPro Biosciences GmbH is dedicated to their mission and emphasizes the importance of accurate and transparent results, which may be relevant to the study of telomerase and its implications in their research.
Highlighted product
Core business
TeloPro Biosciences GmbH
Epiterna
Épalinges, Switzerland
A
1-10 Employees
-
Key takeaway
EPITERNA focuses on translating scientific discoveries into products that can safely slow the aging process and extend life, addressing key health issues related to aging. Their mission is to improve the quality of life for both pets and people by preventing age-related diseases and functional decline.
Highlighted product
Core business
EPITERNA About
Healthycell
Charleston, United States
B
1-10 Employees
2018
Key takeaway
Healthycell offers a product that supports the length of telomeres by providing bioactive phytonutrients that help maintain telomerase levels. This focus on telomere health is part of their commitment to proactive health management through advanced nutrient delivery technology.
Highlighted product
Product
Telomere Length (7-serv) – Healthycell
Support the length of your telomeres with bioactive phytonutrients that help maintain telomerase levels, repair cellular DNA, boost nitric oxide, and inhibit homocysteine.â€
Xcess Biosciences Inc.
San Diego, United States
B
1-10 Employees
2012
Key takeaway
Xcess Biosciences Inc offers Telomerase-IN-2, a potent telomerase inhibitor that decreases dyskerin expression, thereby inhibiting telomerase activity with an IC50 of 0.89 µM. This compound demonstrates anti-cancer activity, making it a valuable product in cancer research.
Highlighted product
Product
Telomerase-IN-2 – Xcess Biosciences
Telomerase-IN-2 is a telomerase inhibitor, and inhibits telomerase activity by decreasing expression of dyskerin, with an IC50 of 0.89 µM. Anti-cancer activity. CAS: 1610878-54-0. 5,7-dimethoxy-3-{4-[4-(pyridine-4-carbonyl)piperazin-1-yl]butoxy}-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one.
MAIA Biotechnology
Chicago, United States
B
1-10 Employees
2018
Key takeaway
MAIA Biotechnology, Inc. is developing innovative cancer therapies, with a focus on telomere targeting through their lead asset, THIO. This investigational drug candidate incorporates a dual mechanism of action that aims to enhance immunogenicity and extend the lives of cancer patients.
Highlighted product
Core business
Home - Maia Biotechnology
THERACELL ADVANCED BIOTECHNOLOGY LTD
Hertsmere, United Kingdom
A
- Employees
2012
Key takeaway
Theracell Advanced Biotechnology is focused on developing innovative cellular and gene therapy products, which are part of the Advanced Therapy Medicinal Products (ATMP) category. Their commitment to personalized regenerative medicine and ongoing research and development activities highlights their role in advancing therapeutic options that could include mechanisms like telomerase in biomedical applications.
Highlighted product
Core business
About - theraCell
Technologies which have been searched by others and may be interesting for you:
Telomerase is an enzyme that plays a crucial role in maintaining the length of telomeres, which are protective caps located at the ends of chromosomes. These telomeres shorten with each cell division, leading to cellular aging and eventual cell death. By adding repetitive nucleotide sequences to the ends of telomeres, telomerase helps to counteract this shortening process, allowing cells to divide more times than they otherwise would. This activity is particularly significant in stem cells, germ cells, and certain cancer cells, where prolonged cell division is necessary for growth and regeneration. Understanding telomerase has implications in aging research and cancer therapies, making it a vital area of study in biotechnology and molecular biology.
Telomerase is an enzyme that plays a crucial role in cellular aging and replication. It functions by adding repetitive nucleotide sequences to the ends of chromosomes, known as telomeres. These telomeres protect the chromosome from degradation and prevent the loss of essential genetic information during cell division. In normal somatic cells, telomerase activity is low or absent, leading to telomere shortening with each cell division. This shortening is associated with aging and limits the number of times a cell can divide. However, in stem cells and certain cancer cells, telomerase is highly active, allowing for indefinite cell division and contributing to tissue regeneration and tumor growth. By maintaining telomere length, telomerase helps ensure cellular longevity and stability.
Telomerase is an enzyme that plays a crucial role in maintaining the length of telomeres, the protective caps at the ends of chromosomes. As cells divide, telomeres shorten, which eventually leads to cell aging and death. In many somatic cells, telomerase activity is low or absent, contributing to the aging process. In contrast, stem cells and certain immune cells express telomerase, which helps preserve their telomere length and extend their lifespan. Research suggests that reactivating telomerase may have implications for slowing down aging and enhancing cellular longevity. However, uncontrolled telomerase activity can lead to cancer, making its regulation a critical area of study in both aging and oncology.
Telomerase plays a crucial role in cellular aging and has been extensively studied in the context of cancer. This enzyme extends the telomeres, which are protective caps at the ends of chromosomes. In normal somatic cells, telomerase activity is low or absent, leading to telomere shortening and eventual cell senescence. However, many cancer cells exhibit high levels of telomerase, allowing them to maintain telomere length, evade apoptosis, and proliferate indefinitely. The activation of telomerase is often associated with tumorigenesis and is considered a hallmark of cancer cells. Thus, while telomerase itself is not a direct cause of cancer, its upregulation is frequently linked to cancer development and progression.
Potential therapies involving telomerase focus on its role in cellular aging and cancer treatment. Researchers are investigating telomerase activation as a means to extend the lifespan of healthy cells, which could lead to advancements in regenerative medicine. This approach aims to enhance tissue repair and combat age-related diseases. On the other hand, telomerase inhibition is being explored in oncology, as many cancer cells express telomerase to maintain their immortality. By targeting telomerase, therapies could effectively limit tumor growth and promote cancer cell death. The dual aspects of telomerase in both promoting longevity in healthy cells and suppressing cancer cell proliferation highlight its significance in potential therapeutic approaches.
Some interesting numbers and facts about your company results for Telomerase
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 4000 |
| Amount of suitable service providers | 3055 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 2005 |
| Youngest suiting company | 2019 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for Telomerase
What are related technologies to Telomerase?
Based on our calculations related technologies to Telomerase are Aromatics, Desiccants, Refrigerants, Resins, Green Chemistry
Which industries are mostly working on Telomerase?
The most represented industries which are working in Telomerase are Biotechnology, IT, Software and Services, Other, Telecommunications, Healthcare
How does ensun find these Telomerase Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
